Ashar Bhavesh 4
4 · Tyra Biosciences, Inc. · Filed Dec 1, 2025
Insider Transaction Report
Form 4
Ashar Bhavesh
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-12-01+300,000→ 300,000 totalExercise: $20.81Exp: 2035-11-30→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on December 1, 2026, and 1/48th of the total number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.